CX 2021 Programme
-
Live stream 1
- Live stream 2
- Abstracts on demand
If you have any questions concerning the scientific programme, please contact us at cxsymposium@bibamedical.com
Times in GMT. Programme subject to change.
The Hurting Leg: - Thursday, 22nd April
Venue: Livestream 1
Time: 14:00 - 19:30
The hurting leg and COVID
Moderators: | Keith Harding, Cardiff, United Kingdom |
Michael Edmonds, London, United Kingdom |
The effect of COVID-19 on amputation rates across a twenty-nine hospital system
Speaker: | Alisha Oropallo, New York, United States |
Opportunity from crisis: Reducing time to treatment for patients with critical limb ischaemia during the coronavirus pandemic
Speaker: | James Morris, Salford, United Kingdom |
Clinical evaluation of CLTI patients and other frail patients in the era of COVID-19
Speaker: | Misti Malone, FDA, Silver Spring, United States |
Networking break
Novel technology controversies
Moderators: | Thomas Zeller, Bad Krozingen, Germany |
Gunnar Tepe, Rosenheim, Germany |
Amputation-free survival and limb salvage with deep venous arterialisation
Speaker: | Peter Schneider, San Francisco, United States |
The impact of socio-economic and clinical variables on the incidence of major amputation in people with diabetic foot ulcers
Speaker: | William Jeffcoate, Nottingham, United Kingdom |
Results of the PRELUDE-BTK study: Novel serration angioplasty balloon for the below-the-knee arteries
Speaker: | Andrew Holden, Auckland, New Zealand |
CX Debate: Paclitaxel-coated balloon should be treatment of choice for preventing restenosis in below-the-knee interventions
For the motion
Francesco Liistro, Arezzo, Italy |
Against the motion
Robert Hinchliffe, Bristol, United Kingdom |
The hurting leg controversies
Moderators: | Andrew Holden, Auckland, New Zealand |
Robert Hinchliffe, Bristol, United Kingdom |
Chronic limb-threatening ischaemia: Options for treatment - open surgery vein and grafts
Speaker: | Richard Neville, San Francisco, United States |
Podium 1st: Five-year outcomes of DCB treatment in critical limb ischaemia from the IN.PACT Global Study
Speaker: | Michel Reijnen, Arnhem, Netherlands |
Catheter-directed thrombolysis versus aspiration thrombectomy in the management of acute limb ischaemia - lessons learned from a multicentre retrospective physician-initiated registry
Speaker: | Maria Antonella Ruffino, Turin, Italy |
Prediction model for freedom from TLR from a multi-study analysis of long-term results with a drug-eluting stent
Speaker: | Michael Dake, Tucson, United States |
Budget impact analysis of heparin-bonded ePTFE grafts against standard ePTFE grafts for below-the-knee bypass in patients with critical limb ischaemia
Speaker: | Yann Goueffic, Nantes, France |
Experience and long-term outcomes with infrapopliteal drug-eluting stents in patients with critical limb ischaemia
Speaker: | Claudia Riera, Barcelona, Spain |
Networking break
Intervention considerations controversies
Moderators: | Thomas Zeller, Bad Krozingen, Germany |
Andrew Holden, Auckland, New Zealand |
Impact of chronic kidney disease on the outcomes of infrapopliteal venous and heparin-bonded expanded polytetrafluoroethylene bypass surgeries
Speaker: | Markus Steinbauer, President DGG, Regensburg, Germany |
PRESTIGE Trial: Multicentre trial analysing IVUS-guided atherectomy below-the-knee in patients with critical limb ischaemia
Speaker: | Michael Lichtenberg, Arnsberg, Germany |
Functional outcome after major limb amputation in vascular surgery
Speaker: | Arsalan Wafi, Southall, United Kingdom |
Roundtable: Unacceptable high major amputation rate - urgent advance needed
The diabetologist's perspective
Speaker: | Michael Edmonds, London, United Kingdom |
The vascular surgeon's perspective
Speaker: | Robert Hinchliffe, Bristol, United Kingdom |
The interventional radiologist's perspective
Speaker: | Gunnar Tepe, Rosenheim, Germany |